➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
AstraZeneca
Dow
Harvard Business School
Johnson and Johnson

Last Updated: October 26, 2021

DrugPatentWatch Database Preview

Litigation Details for Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. (D. Del. 2019)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd.
The small molecule drug covered by the patents cited in this case is ⤷  Free Forever Trial .

Details for Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-10-17 1 Complaint expiration of U.S. Patents Nos. 8,101,659 (the “’659 patent”), 8,796,331 (the “’331 patent”), 8,877,938 (… (the “’938 patent”), and/or 9,388,134 (the “’134 patent”). … THE PATENTS-IN-SUIT AND ENTRESTO® 178. Novartis is the owner of the ’659 patent, titled…copy of the ’659 patent is attached hereto as Exhibit A. 179. The ’659 patent claims, inter alia…the ’331 patent, titled “Methods of treatment and pharmaceutical composition.” The ’331 patent was duly External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Baxter
Johnson and Johnson
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.